Klein Michelle, Iazzettii Loretta, Speiser Phyllis, Carey Dennis, Shelov Steven, Accacha Siham, Fennoy Ilene, Rosenbaum Michael, Rapaport Robert
Department of Pediatrics, Division of Pediatric Endocrinology, Mount Sinai Medical Center, New York, USA.
Department of Pediatrics, Division of Pediatric Endocrinology, Cohen Children's Medical Center, New York, USA.
J Diabetes. 2015 Sep;7(5):649-56. doi: 10.1111/1753-0407.12221. Epub 2014 Dec 23.
Elevated levels of alanine aminotransferase (ALT) are associated with obesity and are often a consequence of non-alcoholic fatty liver disease (NAFLD). The aim of the present study was to assess the relationship between ALT and risk factors for adiposity-related co-morbidities in a diverse population of middle school children.
We measured height, weight, body fatness (bioelectrical impedance), waist circumference, insulin sensitivity, phase 1 insulin release (acute insulin response following intravenous glucose), beta-cell function (acute insulin response corrected for insulin sensitivity), ALT, lipid profiles, and circulating concentrations of interleukin-6 (IL-6), C-reactive protein, adiponectin, and tumor necrosis factor-α (TNF-α) in a multi-ethnic/racial population of 106 middle school students (aged 11-14 years, 45 female) of varying body mass indexes (BMI).
Alanine aminotransferase was significantly correlated with BMI, % body fat, fat mass, waist circumference, fasting insulin, insulin resistance, triglycerides, and was inversely correlated with high-density lipoprotein cholesterol in children, even though all values of ALT were "normal" (range of 4.0-33.0 U/L). ALT was significantly higher in males than females even when corrected for body fatness. Significant correlations with lipids and insulin resistance persisted even when adjusted for age, gender, and body fatness.
Even within the normative range, ALT levels were significantly correlated with anthropomorphic and biochemical risk factors for adiposity-related co-morbidities in youth. Therefore, because ALT is correlated with dyslipidemia, insulin resistance, and central fat distribution, it might also serve as a marker of risk for adiposity-related co-morbidities beyond NAFLD.
丙氨酸氨基转移酶(ALT)水平升高与肥胖相关,且常常是非酒精性脂肪性肝病(NAFLD)的结果。本研究的目的是评估在一个多样化的中学生群体中,ALT与肥胖相关合并症的危险因素之间的关系。
我们测量了106名不同体重指数(BMI)的多民族/种族中学生(年龄11 - 14岁,45名女性)的身高、体重、体脂率(生物电阻抗法)、腰围、胰岛素敏感性、1期胰岛素释放(静脉注射葡萄糖后的急性胰岛素反应)、β细胞功能(校正胰岛素敏感性后的急性胰岛素反应)、ALT、血脂谱以及白细胞介素-6(IL-6)、C反应蛋白、脂联素和肿瘤坏死因子-α(TNF-α)的循环浓度。
即使所有ALT值均“正常”(范围为4.0 - 33.0 U/L),丙氨酸氨基转移酶与儿童的BMI、体脂百分比、脂肪量、腰围、空腹胰岛素、胰岛素抵抗、甘油三酯显著相关,且与高密度脂蛋白胆固醇呈负相关。即使校正体脂后,男性的ALT仍显著高于女性。即使在调整年龄、性别和体脂后,与血脂和胰岛素抵抗的显著相关性仍然存在。
即使在正常范围内,ALT水平与青少年肥胖相关合并症的人体测量和生化危险因素也显著相关。因此,由于ALT与血脂异常、胰岛素抵抗和中心性脂肪分布相关,它可能也可作为除NAFLD之外的肥胖相关合并症风险的标志物。